Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19447518 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1
Condition: Hepatitis C, Chronic
Interventions: Drug: Albuferon;   Drug: Ribavirin;   Drug: PEG-IFNalfa2a

Indicates status has not been verified in more than two years